We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Heidelberg Institute for Radiation Oncology

Heidelberg Institute for Radiation Oncology (HIRO)

Next HIRO-OncoRay Lecture

The next part of our HIRO-OncoRay Lecture Series has alerady started. More information and all dates are available on our website here.

The Heidelberg Institute for Radiation Oncology (HIRO) is a joint initiative between of the German Cancer Research Center (DKFZ), the University Hospital Heidelberg, the Medical Faculty Heidelberg of Heidelberg University and the Heidelberg Ion Beam Therapy Center (HIT). It represents the Heidelberg side in the National Center for Radiation Research in Oncology (NCRO).

The aim of the HIRO is to improve the therapy of cancer through a physically and biologically optimized radiotherapy. To this end, the HIRO covers the entire chain from basic research through the conduct of clinical studies to clinical care and includes all aspects of radiooncology, radiation physics, medical informatics and radiation biology.

More information about HIRO:

Operating Partners

German Cancer Research Center

Heidelberg University Hospital

Heidelberg Ion-Beam Therapy Center (HIT)

Medical Faculty Heidelberg, Heidelberg University